Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Elicio Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −8 vs. Q3 2022
- Shares held
- 4.91M
- −205.9K (−4.0%) vs. Q3 2022
- Total value
- $3.98M
- −$722.7K (−15.4%) vs. Q3 2022
- New holders
- 0
- 6 more added
- Sold out
- 8
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 146 | $118 | 0.00% | +5+3.5% | Added |
| Barclays PLC | 3,617 | $2.94K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,579 | $3.00K | 0.00% | +1,126+45.9% | Added |
| Citigroup Inc | 3,743 | $3.04K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 4,786 | $3.88K | 0.00% | −1,618−25.3% | Reduced |
| UBS Group AG | 9,919 | $8.04K | 0.00% | +2,679+37.0% | Added |
| State Street Corp | 12,700 | $10.3K | 0.00% | 00.0% | Unchanged |
| BLB&B Advisors, LLC | 15,495 | $12.6K | 0.00% | −7,500−32.6% | Reduced |
| Steward Partners Investment Advisory, LLC | 15,558 | $12.6K | 0.00% | 00.0% | Unchanged |
| CAPROCK Group, Inc. | 15,726 | $12.8K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 20,390 | $16.5K | 0.00% | −9,892−32.7% | Reduced |
| Patriot Financial Group Insurance Agency, LLC | 21,500 | $17.4K | 0.00% | −15,000−41.1% | Reduced |
| Acadian Asset Management LLC | 24,704 | $19.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 33,788 | $27.4K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 34,400 | $27.9K | 0.00% | 00.0% | Unchanged |
| Valeo Financial Advisors, LLC | 36,951 | $30.0K | 0.00% | −26,708−42.0% | Reduced |
| Cannell Capital LLC | 40,181 | $32.6K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 52,913 | $42.9K | 0.00% | −25,944−32.9% | Reduced |
| Birchview Capital, LP | 54,392 | $44.0K | 0.03% | 00.0% | Unchanged |
| BlackRock Inc. | 55,272 | $44.9K | 0.00% | +1,188+2.2% | Added |
| Raymond James & Associates | 60,000 | $48.7K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 75,342 | $61.0K | 0.00% | −50,261−40.0% | Reduced |
| Renaissance Technologies LLC | 121,700 | $99.0K | 0.00% | −87,277−41.8% | Reduced |
| Geode Capital Management, LLC | 168,436 | $136.0K | 0.00% | −451−0.3% | Reduced |
| Bridgeway Capital Management, LLC | 175,000 | $142.0K | 0.00% | 00.0% | Unchanged |
| Park West Asset Management LLC | 370,724 | $300.9K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 644,035 | $522.7K | 0.00% | +675+0.1% | Added |
| CM Management, LLC | 732,178 | $594.0K | 0.71% | +132,178+22.0% | Added |
| Nantahala Capital Management, LLC | 1,033,145 | $838.5K | 0.08% | −32,867−3.1% | Reduced |
| BVF Inc | 1,071,297 | $869.5K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −14,675−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −13,661−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −14,592−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,330−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −13,566−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −12,614−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −2,333−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −458−100.0% | Sold out |